Nonprofit patient advocacy group
Appears in 1 story · Last updated Nov 22, 2026
Publicly welcomed the approval
For people with Type 3 Gaucher disease, enzyme infusions have kept the body working while the brain kept slipping. The Food and Drug Administration has now approved Infilbray, the first drug cleared to treat the disease's neurological symptoms.
Updated 1 hour ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?